TB-500 and BPC-157 are two of the most researched peptides in the recovery and repair category. While they are often discussed together — and frequently combined in blended formulations — they have distinct mechanisms of action and different bodies of supporting research.
BPC-157: Localized Repair and Gut Protection
BPC-157 is a 15-amino acid sequence derived from human gastric juice. Its research profile is centered on localized tissue repair, with studies demonstrating accelerated healing of tendons, ligaments, and muscle in animal models. It has also shown consistent gastroprotective effects, making it one of the more versatile peptides in the recovery research space.
TB-500: Systemic Mobility and Actin Regulation
TB-500 is a synthetic version of Thymosin Beta-4, a naturally occurring peptide present in virtually all human and animal cells. Its primary mechanism involves the regulation of actin, a protein essential for cell structure and movement. Research suggests TB-500 promotes cell migration and differentiation, which may support systemic recovery and flexibility in ways that complement BPC-157's more localized effects.
Why Researchers Combine Them
The complementary mechanisms of BPC-157 and TB-500 have made their combination a common protocol in preclinical research. Peptagon's Wolverine Blend provides both peptides in a single vial — BPC-157 10mg and TB-500 10mg — independently tested and shipped with a full COA.
Purity Is Non-Negotiable
When combining peptides in research, purity becomes even more critical. Impurities in either compound can confound results and make it impossible to attribute observed effects to the correct peptide. All Peptagon blends undergo independent HPLC testing on each individual component before blending.
